Generic Injectables Market
1 Introduction to Research & Analysis Reports
1.1 Generic Injectables Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Generic Injectables Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Generic Injectables Overall Market Size
2.1 Global Generic Injectables Market Size: 2021 VS 2028
2.2 Global Generic Injectables Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Generic Injectables Players in Global Market
3.2 Top Global Generic Injectables Companies Ranked by Revenue
3.3 Global Generic Injectables Revenue by Companies
3.4 Top 3 and Top 5 Generic Injectables Companies in Global Market, by Revenue in 2021
3.5 Global Companies Generic Injectables Product Type
3.6 Tier 1, Tier 2 and Tier 3 Generic Injectables Players in Global Market
3.6.1 List of Global Tier 1 Generic Injectables Companies
3.6.2 List of Global Tier 2 and Tier 3 Generic Injectables Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Generic Injectables Market Size Markets, 2021 & 2028
4.1.2 Small Molecule
4.1.3 Large Molecule
4.2 By Type - Global Generic Injectables Revenue & Forecasts
4.2.1 By Type - Global Generic Injectables Revenue, 2017-2022
4.2.2 By Type - Global Generic Injectables Revenue, 2023-2028
4.2.3 By Type - Global Generic Injectables Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Generic Injectables Market Size, 2021 & 2028
5.1.2 Oncology
5.1.3 Anesthesia
5.1.4 Anti-Infectives
5.1.5 Parenteral Nutrition
5.1.6 Cardiovascular Diseases
5.2 By Application - Global Generic Injectables Revenue & Forecasts
5.2.1 By Application - Global Generic Injectables Revenue, 2017-2022
5.2.2 By Application - Global Generic Injectables Revenue, 2023-2028
5.2.3 By Application - Global Generic Injectables Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Generic Injectables Market Size, 2021 & 2028
6.2 By Region - Global Generic Injectables Revenue & Forecasts
6.2.1 By Region - Global Generic Injectables Revenue, 2017-2022
6.2.2 By Region - Global Generic Injectables Revenue, 2023-2028
6.2.3 By Region - Global Generic Injectables Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Generic Injectables Revenue, 2017-2028
6.3.2 US Generic Injectables Market Size, 2017-2028
6.3.3 Canada Generic Injectables Market Size, 2017-2028
6.3.4 Mexico Generic Injectables Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Generic Injectables Revenue, 2017-2028
6.4.2 Germany Generic Injectables Market Size, 2017-2028
6.4.3 France Generic Injectables Market Size, 2017-2028
6.4.4 U.K. Generic Injectables Market Size, 2017-2028
6.4.5 Italy Generic Injectables Market Size, 2017-2028
6.4.6 Russia Generic Injectables Market Size, 2017-2028
6.4.7 Nordic Countries Generic Injectables Market Size, 2017-2028
6.4.8 Benelux Generic Injectables Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Generic Injectables Revenue, 2017-2028
6.5.2 China Generic Injectables Market Size, 2017-2028
6.5.3 Japan Generic Injectables Market Size, 2017-2028
6.5.4 South Korea Generic Injectables Market Size, 2017-2028
6.5.5 Southeast Asia Generic Injectables Market Size, 2017-2028
6.5.6 India Generic Injectables Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Generic Injectables Revenue, 2017-2028
6.6.2 Brazil Generic Injectables Market Size, 2017-2028
6.6.3 Argentina Generic Injectables Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Generic Injectables Revenue, 2017-2028
6.7.2 Turkey Generic Injectables Market Size, 2017-2028
6.7.3 Israel Generic Injectables Market Size, 2017-2028
6.7.4 Saudi Arabia Generic Injectables Market Size, 2017-2028
6.7.5 UAE Generic Injectables Market Size, 2017-2028
7 Players Profiles
7.1 Hospira (Pfizer Inc.)
7.1.1 Hospira (Pfizer Inc.) Corporate Summary
7.1.2 Hospira (Pfizer Inc.) Business Overview
7.1.3 Hospira (Pfizer Inc.) Generic Injectables Major Product Offerings
7.1.4 Hospira (Pfizer Inc.) Generic Injectables Revenue in Global Market (2017-2022)
7.1.5 Hospira (Pfizer Inc.) Key News
7.2 Fresenius Kabi
7.2.1 Fresenius Kabi Corporate Summary
7.2.2 Fresenius Kabi Business Overview
7.2.3 Fresenius Kabi Generic Injectables Major Product Offerings
7.2.4 Fresenius Kabi Generic Injectables Revenue in Global Market (2017-2022)
7.2.5 Fresenius Kabi Key News
7.3 Sandoz (Novartis)
7.3.1 Sandoz (Novartis) Corporate Summary
7.3.2 Sandoz (Novartis) Business Overview
7.3.3 Sandoz (Novartis) Generic Injectables Major Product Offerings
7.3.4 Sandoz (Novartis) Generic Injectables Revenue in Global Market (2017-2022)
7.3.5 Sandoz (Novartis) Key News
7.4 Hikma Pharmaceuticals PLC
7.4.1 Hikma Pharmaceuticals PLC Corporate Summary
7.4.2 Hikma Pharmaceuticals PLC Business Overview
7.4.3 Hikma Pharmaceuticals PLC Generic Injectables Major Product Offerings
7.4.4 Hikma Pharmaceuticals PLC Generic Injectables Revenue in Global Market (2017-2022)
7.4.5 Hikma Pharmaceuticals PLC Key News
7.5 Dr. Reddy?s Laboratories Ltd
7.5.1 Dr. Reddy?s Laboratories Ltd Corporate Summary
7.5.2 Dr. Reddy?s Laboratories Ltd Business Overview
7.5.3 Dr. Reddy?s Laboratories Ltd Generic Injectables Major Product Offerings
7.5.4 Dr. Reddy?s Laboratories Ltd Generic Injectables Revenue in Global Market (2017-2022)
7.5.5 Dr. Reddy?s Laboratories Ltd Key News
7.6 Grifols
7.6.1 Grifols Corporate Summary
7.6.2 Grifols Business Overview
7.6.3 Grifols Generic Injectables Major Product Offerings
7.6.4 Grifols Generic Injectables Revenue in Global Market (2017-2022)
7.6.5 Grifols Key News
7.7 Nichi-Iko Group (Sagent)
7.7.1 Nichi-Iko Group (Sagent) Corporate Summary
7.7.2 Nichi-Iko Group (Sagent) Business Overview
7.7.3 Nichi-Iko Group (Sagent) Generic Injectables Major Product Offerings
7.7.4 Nichi-Iko Group (Sagent) Generic Injectables Revenue in Global Market (2017-2022)
7.7.5 Nichi-Iko Group (Sagent) Key News
7.8 Teva Pharmaceutical
7.8.1 Teva Pharmaceutical Corporate Summary
7.8.2 Teva Pharmaceutical Business Overview
7.8.3 Teva Pharmaceutical Generic Injectables Major Product Offerings
7.8.4 Teva Pharmaceutical Generic Injectables Revenue in Global Market (2017-2022)
7.8.5 Teva Pharmaceutical Key News
7.9 Auromedics
7.9.1 Auromedics Corporate Summary
7.9.2 Auromedics Business Overview
7.9.3 Auromedics Generic Injectables Major Product Offerings
7.9.4 Auromedics Generic Injectables Revenue in Global Market (2017-2022)
7.9.5 Auromedics Key News
7.10 Sanofi
7.10.1 Sanofi Corporate Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Generic Injectables Major Product Offerings
7.10.4 Sanofi Generic Injectables Revenue in Global Market (2017-2022)
7.10.5 Sanofi Key News
7.11 Gland Pharma
7.11.1 Gland Pharma Corporate Summary
7.11.2 Gland Pharma Business Overview
7.11.3 Gland Pharma Generic Injectables Major Product Offerings
7.11.4 Gland Pharma Generic Injectables Revenue in Global Market (2017-2022)
7.11.5 Gland Pharma Key News
7.12 Endo International PLC
7.12.1 Endo International PLC Corporate Summary
7.12.2 Endo International PLC Business Overview
7.12.3 Endo International PLC Generic Injectables Major Product Offerings
7.12.4 Endo International PLC Generic Injectables Revenue in Global Market (2017-2022)
7.12.5 Endo International PLC Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Generic Injectables Market Opportunities & Trends in Global Market
Table 2. Generic Injectables Market Drivers in Global Market
Table 3. Generic Injectables Market Restraints in Global Market
Table 4. Key Players of Generic Injectables in Global Market
Table 5. Top Generic Injectables Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Generic Injectables Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Generic Injectables Revenue Share by Companies, 2017-2022
Table 8. Global Companies Generic Injectables Product Type
Table 9. List of Global Tier 1 Generic Injectables Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Generic Injectables Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Generic Injectables Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Generic Injectables Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Generic Injectables Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Generic Injectables Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Generic Injectables Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Generic Injectables Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Generic Injectables Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Generic Injectables Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Generic Injectables Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Generic Injectables Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Generic Injectables Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Generic Injectables Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Generic Injectables Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Generic Injectables Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Generic Injectables Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Generic Injectables Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Generic Injectables Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Generic Injectables Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Generic Injectables Revenue, (US$, Mn), 2023-2028
Table 30. Hospira (Pfizer Inc.) Corporate Summary
Table 31. Hospira (Pfizer Inc.) Generic Injectables Product Offerings
Table 32. Hospira (Pfizer Inc.) Generic Injectables Revenue (US$, Mn), (2017-2022)
Table 33. Fresenius Kabi Corporate Summary
Table 34. Fresenius Kabi Generic Injectables Product Offerings
Table 35. Fresenius Kabi Generic Injectables Revenue (US$, Mn), (2017-2022)
Table 36. Sandoz (Novartis) Corporate Summary
Table 37. Sandoz (Novartis) Generic Injectables Product Offerings
Table 38. Sandoz (Novartis) Generic Injectables Revenue (US$, Mn), (2017-2022)
Table 39. Hikma Pharmaceuticals PLC Corporate Summary
Table 40. Hikma Pharmaceuticals PLC Generic Injectables Product Offerings
Table 41. Hikma Pharmaceuticals PLC Generic Injectables Revenue (US$, Mn), (2017-2022)
Table 42. Dr. Reddy?s Laboratories Ltd Corporate Summary
Table 43. Dr. Reddy?s Laboratories Ltd Generic Injectables Product Offerings
Table 44. Dr. Reddy?s Laboratories Ltd Generic Injectables Revenue (US$, Mn), (2017-2022)
Table 45. Grifols Corporate Summary
Table 46. Grifols Generic Injectables Product Offerings
Table 47. Grifols Generic Injectables Revenue (US$, Mn), (2017-2022)
Table 48. Nichi-Iko Group (Sagent) Corporate Summary
Table 49. Nichi-Iko Group (Sagent) Generic Injectables Product Offerings
Table 50. Nichi-Iko Group (Sagent) Generic Injectables Revenue (US$, Mn), (2017-2022)
Table 51. Teva Pharmaceutical Corporate Summary
Table 52. Teva Pharmaceutical Generic Injectables Product Offerings
Table 53. Teva Pharmaceutical Generic Injectables Revenue (US$, Mn), (2017-2022)
Table 54. Auromedics Corporate Summary
Table 55. Auromedics Generic Injectables Product Offerings
Table 56. Auromedics Generic Injectables Revenue (US$, Mn), (2017-2022)
Table 57. Sanofi Corporate Summary
Table 58. Sanofi Generic Injectables Product Offerings
Table 59. Sanofi Generic Injectables Revenue (US$, Mn), (2017-2022)
Table 60. Gland Pharma Corporate Summary
Table 61. Gland Pharma Generic Injectables Product Offerings
Table 62. Gland Pharma Generic Injectables Revenue (US$, Mn), (2017-2022)
Table 63. Endo International PLC Corporate Summary
Table 64. Endo International PLC Generic Injectables Product Offerings
Table 65. Endo International PLC Generic Injectables Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Generic Injectables Segment by Type in 2021
Figure 2. Generic Injectables Segment by Application in 2021
Figure 3. Global Generic Injectables Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Generic Injectables Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Generic Injectables Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Generic Injectables Revenue in 2021
Figure 8. By Type - Global Generic Injectables Revenue Market Share, 2017-2028
Figure 9. By Application - Global Generic Injectables Revenue Market Share, 2017-2028
Figure 10. By Region - Global Generic Injectables Revenue Market Share, 2017-2028
Figure 11. By Country - North America Generic Injectables Revenue Market Share, 2017-2028
Figure 12. US Generic Injectables Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Generic Injectables Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Generic Injectables Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Generic Injectables Revenue Market Share, 2017-2028
Figure 16. Germany Generic Injectables Revenue, (US$, Mn), 2017-2028
Figure 17. France Generic Injectables Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Generic Injectables Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Generic Injectables Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Generic Injectables Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Generic Injectables Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Generic Injectables Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Generic Injectables Revenue Market Share, 2017-2028
Figure 24. China Generic Injectables Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Generic Injectables Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Generic Injectables Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Generic Injectables Revenue, (US$, Mn), 2017-2028
Figure 28. India Generic Injectables Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Generic Injectables Revenue Market Share, 2017-2028
Figure 30. Brazil Generic Injectables Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Generic Injectables Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Generic Injectables Revenue Market Share, 2017-2028
Figure 33. Turkey Generic Injectables Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Generic Injectables Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Generic Injectables Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Generic Injectables Revenue, (US$, Mn), 2017-2028
Figure 37. Hospira (Pfizer Inc.) Generic Injectables Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Fresenius Kabi Generic Injectables Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sandoz (Novartis) Generic Injectables Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Hikma Pharmaceuticals PLC Generic Injectables Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Dr. Reddy?s Laboratories Ltd Generic Injectables Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Grifols Generic Injectables Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Nichi-Iko Group (Sagent) Generic Injectables Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Teva Pharmaceutical Generic Injectables Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Auromedics Generic Injectables Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sanofi Generic Injectables Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Gland Pharma Generic Injectables Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Endo International PLC Generic Injectables Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
